Mechanism
How Ipratropium/Albuterol works
Combines beta-2 receptor stimulation from albuterol with muscarinic receptor blockade from ipratropium, producing additive bronchodilation through two different pathways.
← Respiratory Pharmacology
COMBONBRC High Yield5/5 Importance
Ipratropium/Albuterol Respiratory Pharmacology Guide
Class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style study pearls.
Ipratropium/Albuterol combines two short-acting bronchodilator mechanisms. Albuterol stimulates beta-2 receptors for rapid bronchodilation, while ipratropium blocks muscarinic receptors to reduce acetylcholine-mediated bronchoconstriction. This pairing is especially common in COPD exacerbations. For NBRC-style questions, recognize it as a SABA/SAMA combination rather than a steroid or long-acting maintenance inhaler.
Clinical Pearl
What to remember
DuoNeb pairs a SABA with a SAMA: albuterol opens airways through beta-2 stimulation, while ipratropium blocks vagal bronchoconstriction.
Kinetics
Onset, peak, and duration
1
Onset
About 5 to 15 minutes
2
Peak
About 1 to 2 hours
3
Duration
About 4 to 6 hours
Quick facts
- Subclass
- SAMA/SABA combination
- NBRC importance
- 5/5
- Difficulty
- 2/5
- Brands
- DuoNeb, Combivent Respimat
Common indications
- COPD exacerbation
- COPD bronchospasm
- Patients who benefit from combined beta-agonist and anticholinergic bronchodilation
Adverse effects
- Tremor
- Tachycardia
- Palpitations
- Dry mouth
- Throat irritation
- Hypokalemia
- Blurred vision if aerosol contacts eyes
- Paradoxical bronchospasm
Contraindications
- Hypersensitivity to albuterol, ipratropium, atropine derivatives, or formulation components
Cautions and safety issues
- Use caution with tachyarrhythmias or significant cardiovascular disease
- Use caution with narrow-angle glaucoma
- Use caution with urinary retention or prostatic hyperplasia
- Avoid aerosol contact with eyes
NBRC-style question
NBRC-style pharmacology review
A patient scenario involves copd exacerbation with wheezing. Which medication concept should the respiratory therapy student recognize?
High-yield answer
DuoNeb = SABA + SAMA
Interactive practice
Practice in PharmaGenius
Master this medication through adaptive review of class, mechanism, indications, adverse effects, exam traps, and clinical scenarios. Missed concepts can later be surfaced for targeted remediation.
ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Common Exam Traps
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
- Inhaled corticosteroid combination
- LABA/LAMA combination
- SABA alone
- LAMA alone
- Primary anti-inflammatory controller
High-Yield Clinical Scenarios
- COPD exacerbation with wheezing
- Patient receiving combined short-acting bronchodilator therapy
- Bronchodilator selection when both beta-agonist and anticholinergic effects are desired
Related study paths
Continue building pharmacology mastery
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.